• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
C4 Therapeutics released FY2025 9 Months Earnings on November 6, 2025 EST, with actual revenue of USD 24.93 M and EPS of USD -1.1813
04:00
C4 Therapeutics released FY2025 Q3 earnings on November 6, 2025 (EST), with actual revenue of USD 11.23 M (forecast USD 6.28 M) and actual EPS of USD -0.4432 (forecast USD -0.4086)
04:00
Oct16
C4 Therapeutics Announces Phase 1 Trial Data for Cemsidomide
10:37
Oct1
C4 Therapeutics demonstrates cemsidomide clinical trial progress
14:09
Aug8
C4 Therapeutics released FY2025 Semi-Annual Earnings on August 7 (EST), actual revenue USD 13.7 M, actual EPS USD -0.738
03:00
C4 Therapeutics released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 6.463 M (forecast USD 6.55 M), actual EPS USD -0.37 (forecast USD -0.3925)
03:00

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 11.23 M, Net Income -32.17 M, EPS -0.4432

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 6.463 M, Net Income -26.02 M, EPS -0.3664

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 7.238 M, Net Income -26.32 M, EPS -0.3716

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More